Efficacy and Safety of Sofosbuvir and Ribavirin for Treating Chronic Hepatitis C, Genotype 3: Experience of a Tertiary Care Hospital at Karachi, Pakistan

Background It is estimated that approximately 10 million individuals in Pakistan are infected with hepatitis C virus (HCV). Historically, it was very difficult not just to cure but even treat HCV as available options did not have desirable outcomes. However, the approval of directly acting antiviral...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Cureus
Asıl Yazarlar: Butt, Nazish, Reema, Sehrish, Ali Khan, M, Abbasi, Amanullah, Butt, Sehrish, Khoso, Mohammad M, Akbar, Ali, Haleem, Farhan, Mahesar, Ghulam B, Fahad, Anoshia, Qureshi, Talha
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Cureus 2019
Konular:
Gastroenterology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6561614/
https://ncbi.nlm.nih.gov/pubmed/31205844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.4458
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller